<List><item><source>MED</source><extId>28820437</extId><pmcid>PMC5618093</pmcid><annotations><annotation><prefix>secondary outcome measures (</prefix><exact>NCT03204929</exact><postfix>; Table 2). </postfix><tags><tag><name>NCT03204929</name><uri>http://identifiers.org/clinicaltrials/NCT03204929</uri></tag></tags><id>http://europepmc.org/articles/PMC5618093#europepmc-7844209a5785e4a81c55954c7ef36612</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>eimer’s disease patients (</prefix><exact>NCT02711683</exact><postfix>; Table 2). </postfix><tags><tag><name>NCT02711683</name><uri>http://identifiers.org/clinicaltrials/NCT02711683</uri></tag></tags><id>http://europepmc.org/articles/PMC5618093#europepmc-378a9f6d35322dbcc5151c2fc23a954f</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>e 1 clinical trial (</prefix><exact>NCT02870634</exact><postfix>), and a linked phas</postfix><tags><tag><name>NCT02870634</name><uri>http://identifiers.org/clinicaltrials/NCT02870634</uri></tag></tags><id>http://europepmc.org/articles/PMC5618093#europepmc-859ad8b11fc4a51aff7b8d8baa48a1a1</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>/2 extension trial (</prefix><exact>NCT03136809</exact><postfix>) in amyotrophic lat</postfix><tags><tag><name>NCT03136809</name><uri>http://identifiers.org/clinicaltrials/NCT03136809</uri></tag></tags><id>http://europepmc.org/articles/PMC5618093#europepmc-9faf0049f21559d2a511f66ba084dc39</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>ngton’s disease patients (</prefix><exact>NCT02336633</exact><postfix>; Table 2). </postfix><tags><tag><name>NCT02336633</name><uri>http://identifiers.org/clinicaltrials/NCT02336633</uri></tag></tags><id>http://europepmc.org/articles/PMC5618093#europepmc-46adf0d9df90b00a37dce876a02604cc</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>multiple sclerosis (</prefix><exact>NCT01514370</exact><postfix>, NCT03150966; Table</postfix><tags><tag><name>NCT01514370</name><uri>http://identifiers.org/clinicaltrials/NCT01514370</uri></tag></tags><id>http://europepmc.org/articles/PMC5618093#europepmc-06923b4f2fa14ab685feaf049432d702</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>ple sclerosis (NCT01514370, </prefix><exact>NCT03150966</exact><postfix>; Table 2). </postfix><tags><tag><name>NCT03150966</name><uri>http://identifiers.org/clinicaltrials/NCT03150966</uri></tag></tags><id>http://europepmc.org/articles/PMC5618093#europepmc-68ba3c1c5498226b934923144bc0c903</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation></annotations></item></List>